Books.org participates in affiliate programs including Bookshop.org and the Amazon Services LLC Associates Program. We may earn a commission from qualifying purchases made through links on this page, at no additional cost to you.
Overview
In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system. Unhappy with the success rates of standard chemotherapy and radiation treatments, Ruzic took control of his destiny and began to investigate the cutting-edge cures being developed in research laboratories. Racing to a Cure provides a scathing critique of the chemotherapy culture as well as of unscientific "alternative" therapies and endorses state-of-the-art, molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians.Synopsis
In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system. Unhappy with the success rates of standard chemotherapy and radiation treatments, Ruzic took control of his destiny and began to investigate the cutting-edge cures being developed in research laboratories. Racing to a Cure provides a scathing critique of the chemotherapy culture as well as of unscientific "alternative" therapies and endorses state-of-the-art, molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians.